High-potential Stocks: Top 2 Nifty Contenders
Here is the latest financial fact sheet of DIVIS LABORATORIES. For more details, see the DIVIS LABORATORIES quarterly results and DIVIS LABORATORIES share price. For a sector overview, read our pharmaceuticals sector report.
1 Day | % | 2.8 |
No. of shares | m | 265.47 |
1 Week | % | 0.5 |
1 Month | % | 3.7 |
1 Year | % | 1.6 |
52 week H/L | Rs | 3,949.0/2,730.0 |
No. of Mths Year Ending |
12 Mar-19* |
12 Mar-20* |
12 Mar-21* |
12 Mar-22* |
12 Mar-23* |
5-Yr Chart Click to enlarge
|
---|
DIVIS LABORATORIES EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 1,767 | 2,258 | 3,913 | 5,425 | 4,641 | |
Low | Rs | 995 | 1,467 | 1,824 | 3,562 | 2,730 | |
Sales per share (Unadj.) | Rs | 186.3 | 203.2 | 262.5 | 337.5 | 292.6 | |
Earnings per share (Unadj.) | Rs | 51.0 | 51.9 | 74.7 | 111.5 | 68.7 | |
Diluted earnings per share | Rs | 51.0 | 51.9 | 74.7 | 111.5 | 68.7 | |
Cash flow per share (Unadj.) | Rs | 57.3 | 58.9 | 84.4 | 123.3 | 81.6 | |
Dividends per share (Unadj.) | Rs | 16.00 | 16.00 | 20.00 | 30.00 | 30.00 | |
Adj. dividends per share | Rs | 16.00 | 16.00 | 20.00 | 30.00 | 30.00 | |
Avg Dividend yield | % | 1.2 | 0.9 | 0.7 | 0.7 | 0.8 | |
Book value per share (Unadj.) | Rs | 262.1 | 275.4 | 350.1 | 441.8 | 480.9 | |
Adj. book value per share | Rs | 262.1 | 275.4 | 350.1 | 441.8 | 480.9 | |
Shares outstanding (eoy) | m | 265.47 | 265.47 | 265.47 | 265.47 | 265.47 | |
Price / Sales ratio | x | 7.4 | 9.2 | 10.9 | 13.3 | 12.6 | |
Avg P/E ratio | x | 27.1 | 35.9 | 38.4 | 40.3 | 53.7 | |
P/CF ratio (eoy) | x | 24.1 | 31.6 | 34.0 | 36.5 | 45.2 | |
Price / Book Value ratio | x | 5.3 | 6.8 | 8.2 | 10.2 | 7.7 | |
Dividend payout | % | 31.4 | 30.9 | 26.8 | 26.9 | 43.7 | |
Avg Mkt Cap | Rs m | 366,619 | 494,429 | 761,517 | 1,192,890 | 978,378 | |
Total wages/salary | Rs m | 5,423 | 6,211 | 8,258 | 9,462 | 9,750 |
DIVIS LABORATORIES INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 49,463 | 53,944 | 69,694 | 89,598 | 77,675 | |
Other income | Rs m | 1,556 | 1,896 | 627 | 1,159 | 3,447 | |
Total revenues | Rs m | 51,019 | 55,841 | 70,321 | 90,757 | 81,122 | |
Gross profit | Rs m | 18,730 | 18,232 | 28,611 | 38,811 | 23,691 | |
Depreciation | Rs m | 1,689 | 1,862 | 2,556 | 3,115 | 3,432 | |
Interest | Rs m | 47 | 71 | 21 | 20 | 20 | |
Profit before tax | Rs m | 18,551 | 18,195 | 26,660 | 36,835 | 23,686 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | 5,023 | 4,429 | 6,818 | 7,231 | 5,453 | |
Profit after tax | Rs m | 13,527 | 13,765 | 19,843 | 29,605 | 18,234 | |
Gross profit margin | % | 37.9 | 33.8 | 41.1 | 43.3 | 30.5 | |
Effective tax rate | % | 27.1 | 24.3 | 25.6 | 19.6 | 23.0 | |
Net profit margin | % | 27.3 | 25.5 | 28.5 | 33.0 | 23.5 |
DIVIS LABORATORIES BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 46,501 | 55,735 | 67,906 | 96,104 | 97,437 | |
Current liabilities | Rs m | 8,468 | 18,205 | 17,284 | 24,544 | 15,331 | |
Net working cap to sales | % | 76.9 | 69.6 | 72.6 | 79.9 | 105.7 | |
Current ratio | x | 5.5 | 3.1 | 3.9 | 3.9 | 6.4 | |
Inventory Days | Days | 219 | 76 | 10 | 9 | 8 | |
Debtors Days | Days | 858 | 956 | 878 | 987 | 842 | |
Net fixed assets | Rs m | 41,452 | 38,515 | 45,963 | 50,087 | 51,128 | |
Share capital | Rs m | 531 | 531 | 531 | 531 | 531 | |
"Free" reserves | Rs m | 69,041 | 72,568 | 92,415 | 116,751 | 127,140 | |
Net worth | Rs m | 69,572 | 73,099 | 92,946 | 117,282 | 127,671 | |
Long term debt | Rs m | 0 | 0 | 0 | 0 | 0 | |
Total assets | Rs m | 87,953 | 94,250 | 113,869 | 146,191 | 148,565 | |
Interest coverage | x | 397.4 | 255.8 | 1,270.5 | 1,842.8 | 1,209.5 | |
Debt to equity ratio | x | 0 | 0 | 0 | 0 | 0 | |
Sales to assets ratio | x | 0.6 | 0.6 | 0.6 | 0.6 | 0.5 | |
Return on assets | % | 15.4 | 14.7 | 17.4 | 20.3 | 12.3 | |
Return on equity | % | 19.4 | 18.8 | 21.3 | 25.2 | 14.3 | |
Return on capital | % | 26.7 | 25.0 | 28.7 | 31.4 | 18.6 | |
Exports to sales | % | 83.4 | 83.1 | 84.5 | 87.6 | 85.7 | |
Imports to sales | % | 24.6 | 21.5 | 18.8 | 19.7 | 19.8 | |
Exports (fob) | Rs m | 41,238 | 44,832 | 58,877 | 78,445 | 66,537 | |
Imports (cif) | Rs m | 12,187 | 11,597 | 13,127 | 17,676 | 15,378 | |
Fx inflow | Rs m | 41,238 | 44,832 | 58,877 | 78,445 | 66,537 | |
Fx outflow | Rs m | 12,405 | 11,837 | 13,341 | 17,953 | 15,715 | |
Net fx | Rs m | 28,833 | 32,996 | 45,536 | 60,492 | 50,822 |
DIVIS LABORATORIES CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | 9,543 | 12,159 | 19,469 | 19,118 | 24,597 | |
From Investments | Rs m | -6,854 | -835 | 751 | -21,949 | -27,076 | |
From Financial Activity | Rs m | -2,459 | -10,914 | -349 | -5,324 | -7,972 | |
Net Cashflow | Rs m | 230 | 411 | 19,872 | -8,156 | -10,451 |
Share Holding
Shareholding as on Jun 2023
|
Company Information
|
CHM: Ramesh BV Nimmagadda | COMP SEC: M Satish Choudhury | YEAR OF INC: 1990 | BSE CODE: 532488 | FV (Rs): 2 | DIV YIELD (%): 0.8 |
Read: DIVIS LABORATORIES 2022-23 Annual Report Analysis
More Pharmaceuticals Company Fact Sheets: AUROBINDO PHARMA CIPLA PIRAMAL ENTERPRISES LUPIN DR. REDDYS LAB
Compare DIVIS LABORATORIES With: AUROBINDO PHARMA CIPLA PIRAMAL ENTERPRISES LUPIN DR. REDDYS LAB
After opening the day on a positive note, Indian share markets continued the momentum as the session progressed and ended the day higher.